Effect of adding selegiline to levodopa in early, mild Parkinson's disease. Evidence is insufficient to show that combined treatment increases mortality.
Aaltonen
H
H
Kilkku
O
O
Heinonen
E
E
Mäki-Ikola
O
O
D000978:Antiparkinson Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004338:Drug Combinations; D006801:Humans; D007980:Levodopa / Q000627:therapeutic use*; D010300:Parkinson Disease / Q000188:drug therapy*; D012642:Selegiline / Q000627:therapeutic use*; D016019:Survival Analysis; D016896:Treatment Outcome
D000978:Antiparkinson Agents; D004338:Drug Combinations; D012642:Selegiline; D007980:Levodopa